$ACET 4 SEC Filings

Filed On	Filing
07 Aug 2026	Form 4: Klickstein Lloyd, Director Granted 18,300 Stock Option (Right to Buy)
23 Jun 2026	Form 4: Aftab Blake, Chief Scientific Officer Granted 55,000 Stock Option (Right to Buy)
23 Jun 2026	Form 4: Schor Chen, Director Granted 55,000 Stock Option (Right to Buy)
23 Jun 2026	Form 4: Dubin Steve, Director Granted 4,200 Stock Option (Right to Buy)
23 Jun 2026	Form 4: Chodakewitz Jeffrey, Director Granted 4,200 Stock Option (Right to Buy)
23 Jun 2026	Form 4: Grissinger Michael, Director Granted 4,200 Stock Option (Right to Buy)
23 Jun 2026	Form 4: Sinclair Andrew, Director Granted 4,200 Stock Option (Right to Buy)
23 Jun 2026	Form 4: Peng Katie, Director Granted 4,200 Stock Option (Right to Buy)
23 Jun 2026	Form 4: Klickstein Lloyd, Director Granted 4,200 Stock Option (Right to Buy)
29 Apr 2026	Form 4: Ra Capital MANAGEMENT, L.p., 10% owner and 3 others Disposed of 250,000 shares (Other Transaction) · Acquired 250,000 Pre-Funded Warrant (Right to Buy) (Other Transaction)
13 Apr 2026	Form 4: Ra Capital MANAGEMENT, L.p., 10% owner and 3 others Bought 74,577 shares ($525K) · Bought 74,268 shares ($535K) · Bought 74,751 shares ($543K)
09 Apr 2026	Form 4: Orbimed Advisors Llc, 10% owner and 7 others Sold 31,719 shares ($207K) · Sold 72,939 shares ($468K)
27 Mar 2026	Form 4: Harvey Brian Nicholas, Chief Financial Officer Granted 43,361 Stock Option (Right to Buy)
27 Mar 2026	Form 4: Schor Chen, Director Granted 468,555 Stock Option (Right to Buy)
27 Mar 2026	Form 4: Maltzman Julia D., Chief Medical Officer Granted 72,555 Stock Option (Right to Buy)
27 Mar 2026	Form 4: Healey Don, Chief Technology Officer Granted 43,361 Stock Option (Right to Buy)
27 Mar 2026	Form 4: Aftab Blake, Chief Scientific Officer Granted 72,555 Stock Option (Right to Buy)
27 Jan 2026	Form 4: Aftab Blake, Chief Scientific Officer Gave up 535 shares to cover exercise price or tax ($4.52K)
27 Jan 2026	Form 4: Healey Don, Chief Technology Officer Gave up 535 shares to cover exercise price or tax ($4.52K)
27 Jan 2026	Form 4: Schor Chen, Director Gave up 1,755 shares to cover exercise price or tax ($14.8K)

Comments